secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVAVAX INC (NVAX)
CIK:        0001000694
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001104659-26-002725
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Novavax presents strategic update at J.P. Morgan; 2025 results pending
----------------------------------------------------------------------

- Preliminary financial results for year ended Dec 31, 2025 are being finalized and subject to change.
- No specific financial metrics disclosed; presentation focuses on strategic and business updates.
- Investor presentation delivered at 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026.
- Company cautions that actual results may differ materially from preliminary data.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000694/000110465926002725/0001104659-26-002725-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000694/000110465926002725/tm262897d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-002725

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer